The Psychosocial Burden of Obesity
Moreover, it supports weight management and improves body composition for optimal results
Data analysis Data analysis and its graphical representation was done using GraphPad Prism version 9 and 10
For patients interested in participating in research , the following resources may be helpful: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) search for Parkinson's and GLP-1 trials Parkinson's UK (www.parkinsons.org.uk) information on current research and trial opportunities When to contact your GP or specialist : If you have Parkinson's disease and diabetes, and wish to discuss whether a GLP-1 receptor agonist is appropriate for your diabetes management If you experience new or worsening symptoms whilst taking any medication If you are interested in clinical trial participationyour neurologist can advise on suitable studies Seek urgent medical attention if you experience: Severe, persistent abdominal pain (possible pancreatitis) Persistent vomiting or inability to keep fluids down (risk of dehydration) Signs of dehydration (extreme thirst, dark urine, dizziness) Allergic reaction (rash, swelling, difficulty breathing) Patients should never start, stop, or modify medications without medical supervision
Severe, persistent abdominal pain, particularly if radiating to the back, could indicate pancreatitis and requires immediate medical attention
In theory, the benefits of Semaglutide in controlling blood sugar and aiding in weight management could be helpful in addressing some of these risks
